Skip to main content
WRBY logo

WRBY · Warby Parker Inc.

Track WRBY — free
$28.50 +2.89 (+11.28%) At close · Aug 19
Market Cap
$3.17B
Shares
123.61M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$28.50 Open$25.97 Day$25.83–28.70 52W close$16.49–30.34 Avg vol 30d2.7M Short int17.3M · 14.0% float · 7.2d Short vol53% Last earningsAug 6, 2026 DataSep 2021–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Strong Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +17%
      above
      Price vs 50-day avg +6%
      above
      RSI (14) 60
      neutral
      MACD trend Positive
      52-week position 87%
      near high
      Momentum
      relative strength
      Very Strong
      1-month return +16%
      trailing
      6-month return +11%
      trailing
      YTD return +31%
      this year
      Relative strength 0%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $27 › 200d $24 — 50d above 200d
      Institutional flow Distributing
      -1% holders QoQ · +65 funds added
      Insider flow Distributing
      Net -$265.3K over 90 days · 100% sells
      Short interest Falling
      13.99% of float · ▼ -3.2% MoM · 7.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      303 holders — near 3-yr high, broad support
      Squeeze score 80
      high risk · 0–100
      Fundamentals
      Excellent
      Revenue growth +13%
      Y/Y
      Gross margin 54%
      contracting
      EPS growth +106%
      Y/Y
      Free cash flow $43.7M
      Buyback $100.0M
      authorized
      Balance sheet $286.4M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 74%
      annualized · 1-yr
      Max drawdown −42%
      past year
      ATR 6.1%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 5 of last 5
      Latest guidance · from the 8-K filed Aug 6, 2026
      Net revenue · full year 2026 Initiated $959M – $976M
      prior FY $871.91M midpoint +11.0% Y/Y
      Adjusted EBITDA · full year 2026 Non-GAAP Initiated $117M – $119M
      Prior guidance period ended · from the 8-K filed Nov 6, 2025
      Net revenue · full year 2025 $871M – $874M
      Adjusted EBITDA · full year 2025 $98M – $101M
      Adjusted EBITDA Margin · full year 2025 11.3% – 11.6%
      Guided vs delivered · last 5 settled
      Net revenue full year 2025
      guided $871M – $874M
      $871.91M In line
      Revenue full year 2024
      guided $748M – $758M
      $771.32M Beat +2.4%
      Revenue Q1 2024
      guided $195.5M – $197M
      $200M Beat +1.9%
      Net revenue 2023
      guided $666M – $669M
      $669.77M Beat +0.3%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Buy
      0 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +17% Bullish
      Price vs 50-day avg
      +6% Bullish
      RSI (14)
      60 Neutral
      MACD trend
      Positive Bullish
      52-week position
      87% Bullish
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $27 › 200d $24 — 50d above 200d
      Institutional flow Distributing
      -1% holders QoQ · +65 funds added
      Insider flow Distributing
      Net -$265.3K over 90 days · 100% sells
      Short interest Falling
      13.99% of float · ▼ -3.2% MoM · 7.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      303 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $16 Now $29 · 87% Range high $30
      vs 200-day avg +17% vs 50-day avg +6%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      GAAP → non-GAAP reconciliation
      GAAP Net income (loss) 4.64M
      -2.08M Interest and other income, net
      +607K Provision for income taxes
      +14.07M Depreciation and amortization expense
      +163K Asset impairment charges
      +10.33M Stock-based compensation expense
      +3.95M Non-cash charitable donations
      +1.04M Amortization of cloud-based software implementation costs
      +0K System implementation costs
      +0K Inventory write-downs
      +165K Other costs
      = Adjusted EBITDA 32.88M
      Adjusted Gross Profit non-GAAP $136.9M Q2 2026
      Free Cash Flow non-GAAP $6.8M Q2 2026
      GAAP → non-GAAP reconciliation
      GAAP Net cash provided by operating activities $29.62M
      -$22.86M Purchases of property and equipment
      = Free Cash Flow $6.76M
      Share Repurchase Program authorization $100M Full Year 2025
      Stores opened 47 Full Year 2025
      Total stores 323 Full Year 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      WRBY
      Warby Parker Inc.
      this stock
      $3.17B +30.8% +13.0% 14.0%
      ISRG
      Intuitive Surgical Inc
      $137.90B -29.8% +20.5% 44.8 1.9%
      BDX
      Becton Dickinson & Co
      $49.24B +8.2% 3.7%
      MDLN
      Medline Inc.
      $45.86B -19.3% +11.5% 2.6%
      ALC
      Alcon Inc
      $35.55B -5.8% +10.5% 2.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      303
      % held
      103.8%
      Net QoQ
      +15.8M sh
      Top holder
      FMR LLC
      Held Float
      View
      Held by Funds
      Fund positions
      263
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      17.3M
      Days to cover
      7.2d
      Change
      -564.5K sh
      View
      Short Volume
      Short vol %
      53%
      As of
      Aug 19, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      4.9K
      Value
      $128.0K
      As of
      Jul 31, 2026
      View
      Off-Exchange
      Off-exchange %
      38.7%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$265.3K
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $871.9M
      Net income (FY)
      $1.6M
      EPS diluted
      $0.01
      View
      Buybacks
      Authorized
      $100.0M
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 6, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $269.2K
      Shares
      9.2K
      Filed
      Jul 6, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View
      Investor Relations
      Latest news
      Warby Parker Announces Second Qua…
      Published
      Aug 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      WRBY +12.6% +16.1% +11.1% +6.8% +30.8%
      SPY -0.4% +2.9% +11.6% +3.0% +12.8%
      vs SPY +13.0% +13.2% -0.5% +3.8% +18.0%

      Capital returns

      Buyback program · as of Feb 28, 2026
      Authorized
      $100.00M
      Spent (derived)
      Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1504776 CUSIP 93403J106 13F (30d) 279 filings 278 filers Visit website Investor relations